Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
151.33 x 1 167.95 x 1
Post-market by (Cboe BZX)
167.96 -1.32 (-0.78%) 04/02/25 [NYSE]
151.33 x 1 167.95 x 1
Post-market 167.96 unch (unch) 16:20 ET
Profile for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Quest Diagnostics Inc 500 PLAZA DRIVE SECAUCUS NJ 07094 USA

www.questdiagnostics.com Employees: 56,000 P: 973-520-2700

Sector:

Medical

Description:

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.

Key Statistics

Overview:

Market Capitalization, $K 18,786,354
Enterprise Value, $K 24,537,354
Shares Outstanding, K 110,978
Annual Sales, $ 9,872 M
Annual Net Income, $ 871,000 K
Last Quarter Sales, $ 2,621 M
Last Quarter Net Income, $ 222,000 K
EBIT, $ 1,473 M
EBITDA, $ 1,966 M
60-Month Beta 0.78
% of Insider Shareholders 0.79%
% of Institutional Shareholders 88.06%
Float, K 110,101
% Float 99.21%
Short Volume Ratio 0.50

Growth:

1-Year Return 26.96%
3-Year Return 20.91%
5-Year Return 88.57%
5-Year Revenue Growth 27.78%
5-Year Earnings Growth 36.13%
5-Year Dividend Growth 39.62%

Per-Share Information:

Most Recent Earnings 2.23 on 01/30/25
Next Earnings Date 04/22/25 [BMO]
Earnings Per Share ttm 8.92
EPS Growth vs. Prev Qtr -3.04%
EPS Growth vs. Prev Year 3.72%
Annual Dividend Rate, $ 3.00
Annual Dividend Yield 1.77%
Most Recent Dividend 0.750 on 01/14/25
Next Ex-Dividends Date 04/07/25
Dividend Payable Date 04/21/25
Dividend Payout Ratio 32.68%
Most Recent Split 2-1 on 06/21/05

DGX Ratios

Ratio
Price/Earnings ttm 18.97
Price/Earnings forward 17.46
Price/Earnings to Growth 2.13
Return-on-Equity % 15.07%
Return-on-Assets % 6.72%
Profit Margin % 8.82%
Debt/Equity 0.91
Price/Sales 1.90
Price/Cash Flow 12.60
Price/Book 2.77
Book Value/Share 61.04
Interest Coverage 6.85

DGX Dividends

Date Value
01/14/25 $0.7500
10/04/24 $0.7500
07/08/24 $0.7500
01/16/24 $0.7100
10/05/23 $0.7100
07/10/23 $0.7100
04/06/23 $0.7100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades